We are looking for a highly motivated and curiosity-driven master student to join our lab for one year.

The students will apply cutting-edge tools (e.g. CRISPR, in vivo work with genetically engineered cancer models, transcriptomics, FACS, high-throughput automated live cell imaging and others) to explore targets for combination therapies in lung cancer and leukemia. The projects will involve gene/drug screens in culture and in vivo followed by the validation and mechanistic characterization of identified candidates.


We offer:

• a challenging topic at the cutting edge of cancer research

• weekly lab meetings and journal clubs

• a stimulating and dynamic scientific environment with individual supervision

• financial support according to the guidelines of the FWF


The successful candidates should:

• be exceptionally motivated and talented

• have B.Sc. in the field of molecular biology, cell biology, genetics, biotechnology, biochemistry or equivalent

• previous working experience in a research lab is a plus

• be proficient in English


The starting point for the Master Thesis is January 2nd, 2024.



Interested candidates should send a motivation letter and CV with references to iris.urasjodl(at)meduniwien.ac.at until November 30th, 2023.

Nach oben scrollen